Eli Lilly and Amgen announced refunds for 340B covered entities that purchased certain drugs in 2021.

Eli Lilly and Amgen Announce Refunds, Amgen Issues NDC Change

Two drugmakers recently announced that they will refund 340B covered entities that purchased certain medications following adjustments to their ceiling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.